AwesomeCapital
Search This Blog
Tuesday, December 11, 2018
Oppenheimer Starts Jazz Pharmaceuticals (JAZZ) at Outperform
Oppenheimer analyst Esther Rajavelu initiates coverage on Jazz Pharmaceuticals (NASDAQ: JAZZ) with a Outperform rating
https://www.streetinsider.com/Analyst+Comments/Oppenheimer+Starts+Jazz+Pharmaceuticals+%28JAZZ%29+at+Outperform/14912913.html
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.